HC Wainwright & Co. initiated coverage on Addex Therapeutics with a new price target

4/21/21 6:28:54 AM ET

Biotechnology: Pharmaceutical Preparations

Health Care

HC Wainwright & Co. initiated coverage of Addex Therapeutics with a rating of Buy and set a new price target of $28.00

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$ADXN

Date	Price Target	Rating	Analyst
7/31/2024	$30.00	Neutral → Buy	H.C. Wainwright
2/11/2022	$28.00 → $21.00	Buy	HC Wainwright & Co.